PET/CT System Market

PET/CT System Market Outlook (2024 to 2034)

Revenue from the global PET/CT system market is analyzed to increase to US$ 5.27 billion by the end of 2034, up from US$ 2.92 billion in 2024. Worldwide sales of PET CT systems are forecasted to increase at 6.1% CAGR from 2024 to 2034.

During positron emission tomography (PET), small amounts of radioactive tracers, or radiotracers, are injected into the patient's body. Positrons, which are tiny particles that interact with nearby electrons to create gamma radiation, are released by these tracers.

Computed tomography (CT) imaging uses X-rays to create cross-sectional images of the body. Because CT scans provide detailed anatomical information, doctors observe the inside structure of organs and tissues with good clarity and precision. By combining the two technologies into one integrated device, PET/CT scanners simultaneously capture detailed anatomical data from CT scans and functional metabolic data from PET scans during a single imaging session. By establishing a link between metabolic activity and anatomical structures, medical professionals more effectively diagnose stages, plan therapies, and keep an eye on various ailments by utilizing this synergistic method.

PET/CT systems are a combination of molecular and anatomical imaging modalities that give medical professionals a better understanding of the physiological and pathological processes that take place within the human body. Their precision, adaptability, and non-invasive visualization of structure and function make them preferred tools in the healthcare sector and this factor is significantly contributing to the PET/CT system market size expansion.

Key Market Growth Drivers

• The market for PET/CT systems is being positively influenced by the increasing incidence of cancer globally.
• PET/CT imaging is becoming more popular in the oncology field due to its critical role in cancer diagnosis, staging, therapy planning, and monitoring.
• Key PET/CT system market trends are ongoing advancements in technologies leading to increased sensitivity, quicker scan times, better spatial resolution, and the creation of new radiotracers.
• Increasing importance of PET/CT systems in clinical practices for various medical fields such as neurology, cardiology, and psychiatry.
• Demand for PET/CT systems is increasing for early illness identification and to provide personalized treatments.
• By utilizing PET/CT systems, physicians are able to monitor patients more accurately and their response to treatment. These devices also help them identify the stage of any disease, particularly cancer.
• Integration of machine learning algorithms and artificial intelligence (AI) in PET/CT systems is among the major developments in the market, which are creating new lucrative opportunities.
• Incorporation of machine learning algorithms and AI is enhancing image integration, reconstruction, and analysis.

Report Attribute	Detail
PET/CT System Market Size (2024E)	US$ 2.92 Billion
Forecasted Market Value (2034F)	US$ 5.27 Billion
Global Market Growth Rate (2024 to 2034)	6.1% CAGR
North America Market Share (2024E)	56.3%
East Asia Market Value (2024E)	US$ 321 Million
Sales of High-Range Slice Scanners (<64) (2034F)	US$ 3.11 Billion
Sales of Fixed Scanners (2034F)	US$ 3.97 Billion
Oncology Segment Value (2034F)	US$ 4.68 Billion
Key Companies Profiled	Mediso Ltd.; Bruker Corporation; GE Healthcare; Siemens Healthineers; MR Solutions; General Electric Company; MinFound Medical Systems Co., Ltd.; Koninklijke Philips N.V.; SOFIE; United Imaging Healthcare; Canon, Inc.

What Factor is Mainly Contributing to PET/CT System Market Growth?

“Integration of AI & Machine Learning Algorithms in PET/CT Systems”

Rapid technological advancements in PRT/CT systems that improve performance parameters such as scan time, sensitivity, and spatial resolutions are driving market expansion. By increasing the visibility of minute lesions and anatomical details, higher spatial resolution increases diagnostic accuracy. The incorporation of artificial intelligence (AI) and machine learning algorithms into PET/CT systems is a significant advancement, opening up new, profitable prospects.

Due to increased sensitivity, the system detects even small levels of radiotracer absorption, which facilitates the identification of metabolic issues. Faster scan speeds increase throughput, reduce discomfort for patients, and increase productivity. Other than this, the development of new radiotracers is boosting the demand for PET/CT systems as it helps in more accurate targeting of certain biological processes.

What is Hampering Global Demand Growth for PET/CT Systems?

“High Initial Cost and Continuous Maintenance Expenditure”

High purchasing costs and maintenance expenditures are limiting the adoption and utilization of PET/CT equipment in various healthcare facilities. PET/CT systems are considered capital-intensive purchases in the healthcare sector because hospitals and other medical facilities need to make large initial expenditures on them.

PET/CT systems require continuous maintenance in the form of regular servicing, calibration, and software upgrades, which add to the financial burden. Smaller healthcare facilities such as clinics, small clinical companies, and those working in resource-constrained areas find it costly to purchase and operate PET/CT equipment, which limits their access to this imaging technology area.

Country-wise Insights

The North American region is in a leading position and is poised to hold 56.3% of the global PET/CT system market share in 2024. The market in East Asia is forecast to expand at 7% CAGR from 2024 to 2034 and is generating demand for these systems due to the increasing number of cancer cases.

Why is the United States a Key Market for PET/CT System Producers?

“Market Players Benefitting from Superior Cancer Treatment Facilities and Medical Expertise”

Attribute	United States
Market Value (2024E)	US$ 1.59 Billion
Growth Rate (2024 to 2034)	5.9% CAGR
Projected Value (2034F)	US$ 2.81 Billion

In the North American region, the United States is expected to hold 96.4% of the market share in 2024. The United States is a key market for PET/CT system suppliers due to its advanced healthcare sector. Modern cancer therapies and advanced medical facilities are specialties of the United States. Patients from several countries come to the United States to receive treatment because of superior cancer facilities. Its innovative technology, highly qualified medical professionals, and research-driven methodology make it a top option for cancer treatment.

What is the Market Scenario for PET/CT Systems in China?

“PET/CT Systems Enabling Physicians to Offer Personalized Treatment amid Rising Cancer Cases”

Attribute	China
Market Value (2024E)	US$ 147 Million
Growth Rate (2024 to 2034)	7.2% CAGR
Projected Value (2034F)	US$ 296 Million

The increasing number of cases of cancer in China is a key factor boosting the demand for PET/CT systems. In China, industrialization and pollution are two environmental factors that somehow lead to the onset of cancer. This growing health concern is propelling demand for advanced diagnostic technology such as PET/CT systems.

Healthcare providers are focusing on accurate cancer staging, prompt cancer detection, customized treatment planning, and ongoing therapy response monitoring. With the increasing incidence of cancer, PET/CT devices allow physicians to treat patients with targeted, timely care by providing detailed anatomical and functional data in a single scan session. In the end, this leads to better patient outcomes.

Category-wise Insights

Based on end user, the market is segmented into hospitals, diagnostic centers, cancer research centers, and specialty clinics. The hospital segment is projected to create a high portion of revenue throughout the projection period (2024 to 2034) and is estimated to account for 88.3% of the global market share in 2024.

Which Product Type is Gaining Widespread Attention of Healthcare Providers?

“High-range Slice Scanners Offering Faster Scanning Times and Enhanced Picture Resolution”

Attribute	High-Range Slice Scanners (<64)
Segment Value (2024E)	US$ 1.69 Billion
Growth Rate (2024 to 2034)	6.3% CAGR
Projected Value (2034F)	US$ 3.11 Billion

High-range slice scanners (<64) provide quicker scanning times and greater picture resolution, both necessary for detailed imaging and quick patient rotation in busy clinical settings. Better image quality and diagnostic precision brought about by technological improvements have further increased the appeal of these scanners for medical professionals. Due to companies' efforts and market competition, the price of these scanners is decreasing, which increases their utilization in various healthcare facilities such as hospitals, diagnostic centers, specialty clinics, and others.

Why are PET/CT Systems Indispensable for Cancer Treatment Planning?

“Advanced Imaging Capabilities of PET/CT Systems Facilitating Detection of Diverse Cancer Types”

Attribute	Oncology
Segment Value (2024E)	US$ 2.6 Billion
Growth Rate (2024 to 2034)	6.1% CAGR
Projected Value (2034F)	US$ 4.68 Billion

Under the application category, oncology is estimated to account for 88.9% of the worldwide market share in 2024. The application of PET/CT systems is increasing in oncology due to their excellent ability to detect and locate cancerous tumors accurately within the human body. Oncologists can accurately grade cancer, track the disease's response to treatment, and plan for more interventions due to the comprehensive metabolic and anatomical information provided by PET/CT scans. PET/CT systems are extremely useful for the detection and treatment of several cancer types because of their advanced imaging capabilities.

Competitive Landscape

Key players in the PET/CT system industry are focusing on the integration of machine learning algorithms and artificial intelligence (AI) to improve the quality of results and analysis.

• In February 2024, United Imaging Healthcare Europe, a leading manufacturer of advanced medical imaging and radiation equipment, announced the launch of its first mobile digital PET/CT solution in Italy.
• In December 2023, in Tulsa, Ascension St. John announced the launch of the first transportable PET/CT equipment that is entirely digital.
• In November 2023, the United States FDA approved the Biograph Vision.X system 510(k) to provide a range of technical benefits using positron emission tomography/computed tomography (PET/CT).
• In September 2023, the installation of the cutting-edge Biograph 64, Vision 600 - PET-CT scanner was announced by Kokilaben Dhirubhai Ambani Hospital in India. This makes the hospital the first in the country to provide the most recent digital PET/CT imaging equipment, which is a major advancement in the battle against cancer since it allows for the early diagnosis of malignancies and other abnormalities.

Fact.MR provides detailed information about the price points of leading PET/CT system manufacturers positioned across the world, sales growth, production capacity, and speculative technological expansion in this new market report.

Segmentation of PET/CT System Market Research

• By Product Type :

  • Low-Range Slice Scanners (>20)
  • Middle-Range Slice Scanners (21 to 64)
  • High-Range Slice Scanners (<60)

• By Isotope :

  • Fluorodeoxyglucose
  • 62 Cu ATSM
  • 18 F Sodium Fluoride
  • FMISO
  • Gallium
  • Thallium
  • Others

• By Modality :

  • Fixed Scanners
  • Mobile Scanners

• By Application :

  • Oncology
  • Neurology
  • Cardiology
  • Others

• By End User :

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Centers
  • Specialty Clinics

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa